Posted on 11/18/2021 1:03:11 PM PST by Red Badger
A new study published in the journal Science Translational Medicine is reporting the development of a novel mRNA-based vaccine designed to help resist tick bites. Preclinical tests in guinea pigs indicate the vaccine aids the immune system in recognizing tick bites, resulting in the parasites being dislodged before they can transmit any pathogenic disease.
Over a dozen diseases can be transmitted by tick bites. The most well-known is Lyme disease, caused by a bacterium called Borrelia burgdorferi. In the past, vaccines have successfully been developed to specifically target this Lyme disease bacterium. However, this new vaccine candidate takes a different approach, using mRNA technology to target the tick itself.
The vaccine is based on the same mRNA technology that led to the extraordinarily successful rapid development of COVID-19 vaccines in 2020. But instead of directing cells in the body to produce spike proteins to train the body to attack SARS-CoV-2, this particular vaccine directs cells to produce a number of proteins found in the saliva of the black-legged tick Ixodes scapularis.
Dubbed 19ISP, the mRNA vaccine contains instructions for 19 different proteins found in the tick saliva. The preclinical research successfully demonstrated the mRNA vaccine on a number of guinea pigs.
“We found that guinea pigs vaccinated with 19ISP developed skin redness after they were bitten, indicating that their immune system was activated and recruited inflammatory cells to the site to fight off infection,” explains Andaleeb Sajid, co-first author on the study. “Like other animals that developed tick immunity after repeated bites, the ticks were unable to feed on the guinea pigs and quickly detached.”
(Excerpt) Read more at newatlas.com ...
These people are really pushing the mRNA that doesn’t appear to work. Hmmmm!
mRna development was a gigantic bust for drug companies. It was going to be a cancer wonder drug that would be modified for whatever gene type the cancer was in a patient. They spent decades and many billions and got nowhere with it.
Like it or not they are demanding their return on investment no matter how many people they kill.
Lyme is an epidemic. Just undiagnosed.
Your favorite breakfast cereal, NOW with MORE spike proteins!!
The #1 rule in medicine and maintenance work is to do no harm first. If you can't hold true to rule #1, don't fix it.
...as in US citizens I’m sure.
That's what he said - guinea pigs.
well call me when 50% of the population has it. and when big pharma sheds it’s indemnity. even then, i’d wait for the data at this point. don’t trust the cdc or big pharma.
Coming in 2026 - tick protein spray delivered via water cannon to quell the food riots. Dissolving protestors will prove a strong deterrent...
People I don’t trust wanting me to do stuff still applies.
Sorry if I no longer trust the vaccine industry on any level.
Let me guess...96% effective.
Let me guess.
The clot shot causes clots to form inside the tick, so it can’t suck blood - and it dies from starvation; next to the patient that had an “extremely rare” case of sudden death.
mRNAvermectin
Doxycycline for 30 days. About eight bucks. Don’t need anything fancy. They want to turn this thing into aspirin-used for everything.
There were a few years when my immune system could kill ticks, and I read about someone else who did also.
Since the effect wore off, this vaccine would probably need regular boosters.
Pass.
“That’s what he said - guinea pigs.”
...my error. Why I even questioned this is beyond me.
They are bound and determined to get that poison into everyone’s body.
Trying to reinvent ivermectin
I do not think that successful means what they think it means. OTOH, maybe it does. Perhaps they define success by profit rather than lives destroyed and lost.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.